Foresee Pharmaceuticals Co., Ltd. (6576.TWO)
TWD 75.9
(0.0%)
TWD 75.9
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 195.03 Million | 301.5 Million | 226.02 Million | 230.43 Million | 75.19 Million |
| Cost of Revenue | 81.06 Million | 25.53 Million | 50.95 Million | 57 Million | 17.25 Million |
| Gross Profit | 113.97 Million | 275.96 Million | 175.07 Million | 173.43 Million | 57.94 Million |
| Operating Expenses | 1.12 Billion | 745.4 Million | 713.7 Million | 658.22 Million | 528.07 Million |
| Selling, General and Administrative Expenses | 160.15 Million | 124.23 Million | 99.06 Million | 120.58 Million | 109.31 Million |
| Research and Development Expenses | 961.44 Million | 621.17 Million | 614.63 Million | 537.64 Million | 418.75 Million |
| Other Expenses | - | 23.37 Million | 7.79 Million | 1.93 Million | - |
| Cost and Expenses | 1.2 Billion | 770.94 Million | 764.65 Million | 715.23 Million | 545.32 Million |
| Operating Income | -1 Billion | -437.72 Million | -527.31 Million | -481.81 Million | -470.12 Million |
| Interest Expense | 2.84 Million | 402 Thousand | 681 Thousand | 999 Thousand | 521 Thousand |
| Income Tax Expense | 47.66 Million | 34.5 Million | 41.27 Million | 27.89 Million | 17.23 Million |
| Earnings before Tax | -988.63 Million | -438.13 Million | -527.99 Million | -482.81 Million | -469.98 Million |
| Net Income | -1.03 Billion | -472.63 Million | -569.26 Million | -510.71 Million | -487.21 Million |
| Earnings Per Share Basic | -8.14 | -4.00 | -4.80 | -4.98 | -5.08 |
| Earnings Per Share Diluted | -8.14 | -4.00 | -4.80 | -4.98 | -5.08 |
| Weighted Average Shares Outstanding | 127.3 Million | 118.04 Million | 118.67 Million | 102.54 Million | 95.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 127.27 Million | 118.04 Million | 118.67 Million | 102.54 Million | 95.93 Million |
| Gross Margin | 0.58 | 0.92 | 0.77 | 0.75 | 0.77 |
| EBIT Margin | -4.68 | -1.28 | -2.11 | -1.88 | -5.90 |
| Profit Margin | -5.31 | -1.57 | -2.52 | -2.22 | -6.48 |
| EBITDA | -912.16 Million | -386.57 Million | -475.83 Million | -432.32 Million | -430.26 Million |
| Earnings Before Tax Margin | -5.17 | -1.45 | -2.33 | -2.09 | -6.25 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 94.18 Million | 103.85 Million | 68.42 Million | 195.03 Million | 60.72 Million | 37.48 Million |
| Cost of Revenue | 50.74 Million | 62.86 Million | 32.31 Million | 81.06 Million | 17.72 Million | 2.81 Million |
| Gross Profit | 43.43 Million | 40.98 Million | 36.11 Million | 113.97 Million | 42.99 Million | 34.66 Million |
| Operating Expenses | 207.75 Million | 175.66 Million | 354.52 Million | 1.12 Billion | 284.77 Million | 308.22 Million |
| Selling, General and Administrative Expenses | 36.75 Million | 35.7 Million | 42.81 Million | - | 41.57 Million | 39.5 Million |
| Research and Development Expenses | 170.99 Million | 139.96 Million | 311.7 Million | - | 243.19 Million | 268.71 Million |
| Other Expenses | 4.35 Million | 19.57 Million | -21.03 Million | -1.68 Million | 17.62 Million | 2.92 Million |
| Cost and Expenses | 258.5 Million | 238.53 Million | 386.83 Million | 1.2 Billion | 302.49 Million | 311.04 Million |
| Operating Income | -151.5 Million | -106.45 Million | -329.55 Million | -985.78 Million | -214.91 Million | -268.65 Million |
| Interest Expense | 1.41 Million | 1.4 Million | 1.17 Million | 2.84 Million | 920 Thousand | 507 Thousand |
| Income Tax Expense | 11.41 Million | 11.68 Million | 7.83 Million | 47.66 Million | 20.71 Million | 12.77 Million |
| Earnings before Tax | -152.91 Million | -107.85 Million | -330.73 Million | -988.63 Million | -215.83 Million | -269.16 Million |
| Net Income | -164.33 Million | -119.54 Million | -338.56 Million | -1.03 Billion | -236.55 Million | -281.93 Million |
| Earnings Per Share Basic | -1.21 | -0.88 | -2.57 | - | -1.74 | -2.37 |
| Earnings Per Share Diluted | -1.21 | -0.88 | -2.57 | - | -1.74 | -2.37 |
| Weighted Average Shares Outstanding | 135.81 Million | 135.84 Million | 131.61 Million | 127.27 Million | 135.95 Million | 118.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 135.81 Million | 135.84 Million | 131.61 Million | 127.27 Million | 135.95 Million | 118.96 Million |
| Gross Margin | 0.46 | 0.39 | 0.53 | 0.58 | 0.71 | 0.92 |
| EBIT Margin | -1.39 | -0.83 | -4.52 | - | -3.23 | -6.70 |
| Profit Margin | -1.74 | -1.15 | -4.95 | -5.31 | -3.90 | -7.52 |
| EBITDA | -131.22 Million | -86.2 Million | -309.59 Million | - | -196.33 Million | -250.99 Million |
| Earnings Before Tax Margin | -1.61 | -1.03 | -4.82 | -5.05 | -3.54 | -7.17 |
0R02
QRS
XPL
PIK
NLSP
ABDN